Clinical trial
Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, During in Utero Repair of Myelomeningocele
NCT04468568 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, During in Utero Repair of Myelomeningocele
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2017
- Completion date
- April 1, 2022
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myelomeningocele, pregnancy; malformation central nervous system, terbutaline adverse reaction